The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria
Abstract
:1. Introduction and Historical Perspective of Carbapenemases
2. Classification
3. Ambler Class A Carbapenemases
4. Ambler Class B Carbapenemases (Metallo-β-Lactamases)
5. Ambler Class D Carbapenemases (Oxacillinases)
6. Emerging Ambler Class C Carbapenemases
7. Distribution of Carbapenemases Among Gram-Negative Pathogens
7.1. Enterobacteriaceae
7.2. Pseudomonas
7.3. Acinetobacter
7.4. Other Gram-Negative Organisms
8. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Jean, S.-S.; Lee, W.-S.; Lam, C.; Hsu, C.-W.; Chen, R.-J.; Hsueh, P.-R. Carbapenemase-producing Gram-negative bacteria: Current epidemics, antimicrobial susceptibility and treatment options. Future Microbiol. 2015, 10, 407–425. [Google Scholar] [CrossRef] [PubMed]
- Bonomo, R.A.; Burd, E.M.; Conly, J.; Limbago, B.M.; Poirel, L.; Segre, J.A.; Westblade, L.F. Carbapenemase-Producing Organisms: A Global Scourge. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2018, 66, 1290–1297. [Google Scholar] [CrossRef] [PubMed]
- Kanj, S.S.; Kanafani, Z.A. Current concepts in antimicrobial therapy against resistant gram-negative organisms: Extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin. Proc. 2011, 86, 250–259. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bush, K. Past and Present Perspectives on β-Lactamases. Antimicrob. Agents Chemother. 2018, 62. [Google Scholar] [CrossRef] [Green Version]
- Touati, A.; Mairi, A. Carbapenemase-Producing Enterobacterales in Algeria: A Systematic Review. Microb. Drug Resist. Larchmt. N 2019. [Google Scholar] [CrossRef]
- Carfi, A.; Pares, S.; Duée, E.; Galleni, M.; Duez, C.; Frère, J.M.; Dideberg, O. The 3-D structure of a zinc metallo-beta-lactamase from Bacillus cereus reveals a new type of protein fold. EMBO J. 1995, 14, 4914–4921. [Google Scholar] [CrossRef] [Green Version]
- Duval, V.; Swinnen, M.; Lepage, S.; Brans, A.; Granier, B.; Franssen, C.; Frère, J.-M.; Joris, B. The kinetic properties of the carboxy terminal domain of the Bacillus licheniformis 749/I BlaR penicillin-receptor shed a new light on the derepression of beta-lactamase synthesis. Mol. Microbiol. 2003, 48, 1553–1564. [Google Scholar] [CrossRef] [Green Version]
- Queenan, A.M.; Bush, K. Carbapenemases: The versatile beta-lactamases. Clin. Microbiol. Rev. 2007, 20, 440–458. [Google Scholar] [CrossRef] [Green Version]
- Cullmann, W.; Dick, W. Heterogeneity of beta-lactamase production in Pseudomonas maltophilia, a nosocomial pathogen. Chemotherapy 1990, 36, 117–126. [Google Scholar] [CrossRef]
- Yang, Y.J.; Wu, P.J.; Livermore, D.M. Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates. Antimicrob. Agents Chemother. 1990, 34, 755–758. [Google Scholar] [CrossRef] [Green Version]
- Nordmann, P.; Mariotte, S.; Naas, T.; Labia, R.; Nicolas, M.H. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli. Antimicrob. Agents Chemother. 1993, 37, 939–946. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Naas, T.; Nordmann, P. Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein. Proc. Natl. Acad. Sci. USA 1994, 91, 7693–7697. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Watanabe, M.; Iyobe, S.; Inoue, M.; Mitsuhashi, S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 1991, 35, 147–151. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tsakris, A.; Pournaras, S.; Woodford, N.; Palepou, M.F.; Babini, G.S.; Douboyas, J.; Livermore, D.M. Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J. Clin. Microbiol. 2000, 38, 1290–1292. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cardoso, O.; Leitão, R.; Figueiredo, A.; Sousa, J.C.; Duarte, A.; Peixe, L.V. Metallo-beta-lactamase VIM-2 in clinical isolates of Pseudomonas aeruginosa from Portugal. Microb. Drug Resist. Larchmt. N 2002, 8, 93–97. [Google Scholar] [CrossRef] [PubMed]
- Lauretti, L.; Riccio, M.L.; Mazzariol, A.; Cornaglia, G.; Amicosante, G.; Fontana, R.; Rossolini, G.M. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 1999, 43, 1584–1590. [Google Scholar] [CrossRef] [Green Version]
- Crespo, M.P.; Woodford, N.; Sinclair, A.; Kaufmann, M.E.; Turton, J.; Glover, J.; Velez, J.D.; Castañeda, C.R.; Recalde, M.; Livermore, D.M. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia. J. Clin. Microbiol. 2004, 42, 5094–5101. [Google Scholar] [CrossRef] [Green Version]
- Gales, A.C.; Menezes, L.C.; Silbert, S.; Sader, H.S. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. J. Antimicrob. Chemother. 2003, 52, 699–702. [Google Scholar] [CrossRef]
- Walsh, T.R. The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria. Clin. Microbiol. Infect. 2005, 11 (Suppl. 6), 2–9. [Google Scholar] [CrossRef] [Green Version]
- Pournaras, S.; Maniati, M.; Petinaki, E.; Tzouvelekis, L.S.; Tsakris, A.; Legakis, N.J.; Maniatis, A.N. Hospital outbreak of multiple clones of Pseudomonas aeruginosa carrying the unrelated metallo-beta-lactamase gene variants blaVIM-2 and blaVIM-4. J. Antimicrob. Chemother. 2003, 51, 1409–1414. [Google Scholar] [CrossRef] [Green Version]
- Yigit, H.; Queenan, A.M.; Anderson, G.J.; Domenech-Sanchez, A.; Biddle, J.W.; Steward, C.D.; Alberti, S.; Bush, K.; Tenover, F.C. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2001, 45, 1151–1161. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yigit, H.; Queenan, A.M.; Rasheed, J.K.; Biddle, J.W.; Domenech-Sanchez, A.; Alberti, S.; Bush, K.; Tenover, F.C. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2. Antimicrob. Agents Chemother. 2003, 47, 3881–3889. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, C.-R.; Lee, J.H.; Park, K.S.; Kim, Y.B.; Jeong, B.C.; Lee, S.H. Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods. Front. Microbiol. 2016, 7, 895. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Porreca, A.M.; Sullivan, K.V.; Gallagher, J.C. The Epidemiology, Evolution, and Treatment of KPC-Producing Organisms. Curr. Infect. Dis. Rep. 2018, 20, 13. [Google Scholar] [CrossRef] [PubMed]
- Poirel, L.; Héritier, C.; Tolün, V.; Nordmann, P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2004, 48, 15–22. [Google Scholar] [CrossRef] [Green Version]
- Potron, A.; Poirel, L.; Nordmann, P. Derepressed transfer properties leading to the efficient spread of the plasmid encoding carbapenemase OXA-48. Antimicrob. Agents Chemother. 2014, 58, 467–471. [Google Scholar] [CrossRef] [Green Version]
- Potron, A.; Poirel, L.; Rondinaud, E.; Nordmann, P. Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Eurosurveillance 2013, 18, 20549. [Google Scholar] [CrossRef]
- Mugnier, P.D.; Poirel, L.; Naas, T.; Nordmann, P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 2010, 16, 35–40. [Google Scholar] [CrossRef]
- Scaife, W.; Young, H.K.; Paton, R.H.; Amyes, S.G. Transferable imipenem-resistance in Acinetobacter species from a clinical source. J. Antimicrob. Chemother. 1995, 36, 585–586. [Google Scholar] [CrossRef]
- Donald, H.M.; Scaife, W.; Amyes, S.G.; Young, H.K. Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob. Agents Chemother. 2000, 44, 196–199. [Google Scholar] [CrossRef] [Green Version]
- Yong, D.; Toleman, M.A.; Giske, C.G.; Cho, H.S.; Sundman, K.; Lee, K.; Walsh, T.R. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 2009, 53, 5046–5054. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pittalis, S.; Ferarro, F.; Puro, V. NDM-1: The superbug? Infez. Med. 2011, 19, 224–234. [Google Scholar] [PubMed]
- Poirel, L.; Potron, A.; Nordmann, P. OXA-48-like carbapenemases: The phantom menace. J. Antimicrob. Chemother. 2012, 67, 1597–1606. [Google Scholar] [CrossRef] [Green Version]
- Meletis, G.; Chatzidimitriou, D.; Malisiovas, N. Double- and multi-carbapenemase-producers: The excessively armored bacilli of the current decade. Eur. J. Clin. Microbiol. Infect. Dis. 2015, 34, 1487–1493. [Google Scholar] [CrossRef] [PubMed]
- Meletis, G. Carbapenem resistance: Overview of the problem and future perspectives. Ther. Adv. Infect. Dis. 2016, 3, 15–21. [Google Scholar] [CrossRef] [Green Version]
- Bush, K.; Jacoby, G.A.; Medeiros, A.A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 1995, 39, 1211–1233. [Google Scholar] [CrossRef] [Green Version]
- Bush, K. The ABCD’s of β-lactamase nomenclature. J. Infect. Chemother. 2013, 19, 549–559. [Google Scholar] [CrossRef]
- Bush, K.; Jacoby, G.A. Updated functional classification of beta-lactamases. Antimicrob. Agents Chemother. 2010, 54, 969–976. [Google Scholar] [CrossRef] [Green Version]
- Jacoby, G.A. AmpC beta-lactamases. Clin. Microbiol. Rev. 2009, 22, 161–182. [Google Scholar] [CrossRef] [Green Version]
- Bush, K. Characterization of beta-lactamases. Antimicrob. Agents Chemother. 1989, 33, 259–263. [Google Scholar] [CrossRef] [Green Version]
- Hammoudi, D.; Moubareck, C.A.; Sarkis, D.K. How to detect carbapenemase producers? A literature review of phenotypic and molecular methods. J. Microbiol. Methods 2014, 107, 106–118. [Google Scholar] [CrossRef] [PubMed]
- Naas, T.; Vandel, L.; Sougakoff, W.; Livermore, D.M.; Nordmann, P. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia marcescens S6. Antimicrob. Agents Chemother. 1994, 38, 1262–1270. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Henriques, I.; Moura, A.; Alves, A.; Saavedra, M.J.; Correia, A. Molecular characterization of a carbapenem-hydrolyzing class A beta-lactamase, SFC-1, from Serratia fonticola UTAD54. Antimicrob. Agents Chemother. 2004, 48, 2321–2324. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Poirel, L.; Héritier, C.; Podglajen, I.; Sougakoff, W.; Gutmann, L.; Nordmann, P. Emergence in Klebsiella pneumoniae of a chromosome-encoded SHV beta-lactamase that compromises the efficacy of imipenem. Antimicrob. Agents Chemother. 2003, 47, 755–758. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Naas, T.; Dortet, L.; Iorga, B.I. Structural and Functional Aspects of Class A Carbapenemases. Curr. Drug Targets 2016, 17, 1006–1028. [Google Scholar] [CrossRef] [PubMed]
- Dabos, L.; Patiño-Navarrete, R.; Nastro, M.; Famiglietti, A.; Glaser, P.; Rodriguez, C.H.; Naas, T. SME-4-producing Serratia marcescens from Argentina belonging to clade 2 of the S. marcescens phylogeny. J. Antimicrob. Chemother. 2019, 74, 1836–1841. [Google Scholar] [CrossRef] [PubMed]
- Rasmussen, B.A.; Bush, K.; Keeney, D.; Yang, Y.; Hare, R.; O’Gara, C.; Medeiros, A.A. Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae. Antimicrob. Agents Chemother. 1996, 40, 2080–2086. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Boyd, D.A.; Mataseje, L.F.; Davidson, R.; Delport, J.A.; Fuller, J.; Hoang, L.; Lefebvre, B.; Levett, P.N.; Roscoe, D.L.; Willey, B.M.; et al. Enterobacter cloacae Complex Isolates Harboring blaNMC-A or blaIMI-Type Class A Carbapenemase Genes on Novel Chromosomal Integrative Elements and Plasmids. Antimicrob. Agents Chemother. 2017, 61, e02578-16. [Google Scholar] [CrossRef] [Green Version]
- Bratu, S.; Mooty, M.; Nichani, S.; Landman, D.; Gullans, C.; Pettinato, B.; Karumudi, U.; Tolaney, P.; Quale, J. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: Epidemiology and recommendations for detection. Antimicrob. Agents Chemother. 2005, 49, 3018–3020. [Google Scholar] [CrossRef] [Green Version]
- Woodford, N.; Tierno, P.M.; Young, K.; Tysall, L.; Palepou, M.-F.I.; Ward, E.; Painter, R.E.; Suber, D.F.; Shungu, D.; Silver, L.L.; et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center. Antimicrob. Agents Chemother. 2004, 48, 4793–4799. [Google Scholar] [CrossRef] [Green Version]
- Deshpande, L.M.; Rhomberg, P.R.; Sader, H.S.; Jones, R.N. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: Report from the MYSTIC Program (1999–2005). Diagn. Microbiol. Infect. Dis. 2006, 56, 367–372. [Google Scholar] [CrossRef] [PubMed]
- Nordmann, P.; Naas, T.; Poirel, L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 2011, 17, 1791–1798. [Google Scholar] [CrossRef] [PubMed]
- Van Beek, J.; Räisänen, K.; Broas, M.; Kauranen, J.; Kähkölä, A.; Laine, J.; Mustonen, E.; Nurkkala, T.; Puhto, T.; Sinkkonen, J.; et al. Tracing local and regional clusters of carbapenemase-producing Klebsiella pneumoniae ST512 with whole genome sequencing, Finland, 2013 to 2018. Eurosurveillance 2019, 24, 1800522. [Google Scholar] [CrossRef] [PubMed]
- Giddins, M.J.; Macesic, N.; Annavajhala, M.K.; Stump, S.; Khan, S.; McConville, T.H.; Mehta, M.; Gomez-Simmonds, A.; Uhlemann, A.-C. Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates. Antimicrob. Agents Chemother. 2018, 62, e02101-17. [Google Scholar]
- Balm, M.N.D.; Ngan, G.; Jureen, R.; Lin, R.T.P.; Teo, J. Molecular characterization of newly emerged blaKPC-2-producing Klebsiella pneumoniae in Singapore. J. Clin. Microbiol. 2012, 50, 475–476. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Naas, T.; Cuzon, G.; Villegas, M.-V.; Lartigue, M.-F.; Quinn, J.P.; Nordmann, P. Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene. Antimicrob. Agents Chemother. 2008, 52, 1257–1263. [Google Scholar] [CrossRef] [Green Version]
- Galetti, R.; Andrade, L.N.; Varani, A.M.; Darini, A.L.C. A Phage-Like Plasmid Carrying blaKPC-2 Gene in Carbapenem-Resistant Pseudomonas aeruginosa. Front. Microbiol. 2019, 10, 572. [Google Scholar] [CrossRef]
- Hu, Y.-Y.; Wang, Q.; Sun, Q.-L.; Chen, G.-X.; Zhang, R. A novel plasmid carrying carbapenem-resistant gene blaKPC-2 in Pseudomonas aeruginosa. Infect. Drug Resist. 2019, 12, 1285–1288. [Google Scholar] [CrossRef] [Green Version]
- Martinez, T.; Martinez, I.; Vazquez, G.J.; Aquino, E.E.; Robledo, I.E. Genetic environment of the KPC gene in Acinetobacter baumannii ST2 clone from Puerto Rico and genomic insights into its drug resistance. J. Med. Microbiol. 2016, 65, 784–792. [Google Scholar] [CrossRef]
- Caneiras, C.; Calisto, F.; Jorge da Silva, G.; Lito, L.; Melo-Cristino, J.; Duarte, A. First Description of Colistin and Tigecycline-Resistant Acinetobacter baumannii Producing KPC-3 Carbapenemase in Portugal. Antibiot. Basel Switz. 2018, 7, 96. [Google Scholar] [CrossRef] [Green Version]
- Landman, D.; Bratu, S.; Quale, J. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J. Med. Microbiol. 2009, 58, 1303–1308. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhang, Y.; Jiang, X.; Wang, Y.; Li, G.; Tian, Y.; Liu, H.; Ai, F.; Ma, Y.; Wang, B.; Ruan, F.; et al. Contribution of β-lactamases and porin proteins OmpK35 and OmpK36 to carbapenem resistance in clinical isolates of KPC-2-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2014, 58, 1214–1217. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yang, F.; Huang, L.; Li, L.; Yang, Y.; Mao, D.; Luo, Y. Discharge of KPC-2 genes from the WWTPs contributed to their enriched abundance in the receiving river. Sci. Total Environ. 2017, 581–582, 136–143. [Google Scholar] [CrossRef] [PubMed]
- Ekwanzala, M.D.; Budeli, P.; Dewar, J.B.; Kamika, I.; Momba, M.N.B. Draft Genome Sequences of Novel Sequence Type 3559 Carbapenem-Resistant Klebsiella pneumoniae Isolates Recovered from the Environment. Microbiol. Resour. Announc. 2019, 8, e00518-19. [Google Scholar] [CrossRef] [Green Version]
- Poirel, L.; Weldhagen, G.F.; Naas, T.; De Champs, C.; Dove, M.G.; Nordmann, P. GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother. 2001, 45, 2598–2603. [Google Scholar] [CrossRef] [Green Version]
- Viedma, E.; Juan, C.; Acosta, J.; Zamorano, L.; Otero, J.R.; Sanz, F.; Chaves, F.; Oliver, A. Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain. Antimicrob. Agents Chemother. 2009, 53, 4930–4933. [Google Scholar] [CrossRef] [Green Version]
- Ayoub Moubareck, C.; Hammoudi Halat, D.; Akkawi, C.; Nabi, A.; AlSharhan, M.A.; AlDeesi, Z.O.; Peters, C.C.; Celiloglu, H.; Karam Sarkis, D. Role of outer membrane permeability, efflux mechanism, and carbapenemases in carbapenem-nonsusceptible Pseudomonas aeruginosa from Dubai hospitals: Results of the first cross-sectional survey. Int. J. Infect. Dis. 2019, 84, 143–150. [Google Scholar] [CrossRef] [Green Version]
- Garza-Ramos, U.; Barrios, H.; Reyna-Flores, F.; Tamayo-Legorreta, E.; Catalan-Najera, J.C.; Morfin-Otero, R.; Rodríguez-Noriega, E.; Volkow, P.; Cornejo-Juarez, P.; González, A.; et al. Widespread of ESBL- and carbapenemase GES-type genes on carbapenem-resistant Pseudomonas aeruginosa clinical isolates: A multicenter study in Mexican hospitals. Diagn. Microbiol. Infect. Dis. 2015, 81, 135–137. [Google Scholar] [CrossRef]
- Moubareck, C.; Brémont, S.; Conroy, M.-C.; Courvalin, P.; Lambert, T. GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob. Agents Chemother. 2009, 53, 3579–3581. [Google Scholar] [CrossRef] [Green Version]
- Hammoudi, D.; Ayoub Moubareck, C.; Aires, J.; Adaime, A.; Barakat, A.; Fayad, N.; Hakime, N.; Houmani, M.; Itani, T.; Najjar, Z.; et al. Countrywide spread of OXA-48 carbapenemase in Lebanon: Surveillance and genetic characterization of carbapenem-non-susceptible Enterobacteriaceae in 10 hospitals over a one-year period. Int. J. Infect. Dis. 2014, 29, 139–144. [Google Scholar] [CrossRef] [Green Version]
- Van Duin, D.; Doi, Y. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence 2017, 8, 460–469. [Google Scholar] [CrossRef] [PubMed]
- Jeon, J.H.; Lee, J.H.; Lee, J.J.; Park, K.S.; Karim, A.M.; Lee, C.-R.; Jeong, B.C.; Lee, S.H. Structural basis for carbapenem-hydrolyzing mechanisms of carbapenemases conferring antibiotic resistance. Int. J. Mol. Sci. 2015, 16, 9654–9692. [Google Scholar] [CrossRef] [PubMed]
- Walsh, T.R.; Toleman, M.A.; Poirel, L.; Nordmann, P. Metallo-beta-lactamases: The quiet before the storm? Clin. Microbiol. Rev. 2005, 18, 306–325. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kuwabara, S.; Abraham, E.P. Some properties of two extracellular beta-lactamases from Bacillus cereus 569/H. Biochem. J. 1967, 103, 27C–30C. [Google Scholar] [CrossRef]
- Rasmussen, B.A.; Kovacs, E. Identification and DNA sequence of a new Bacteroides fragilis insertion sequence-like element. Plasmid 1991, 25, 141–144. [Google Scholar] [CrossRef]
- Podglajen, I.; Breuil, J.; Casin, I.; Collatz, E. Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and by analysis of PCR-generated fragment patterns and insertion sequence content. J. Bacteriol. 1995, 177, 5270–5275. [Google Scholar] [CrossRef] [Green Version]
- Podglajen, I.; Breuil, J.; Collatz, E. Insertion of a novel DNA sequence, 1S1186, upstream of the silent carbapenemase gene cfiA, promotes expression of carbapenem resistance in clinical isolates of Bacteroides fragilis. Mol. Microbiol. 1994, 12, 105–114. [Google Scholar] [CrossRef]
- Diene, S.M.; Rolain, J.-M. Carbapenemase genes and genetic platforms in Gram-negative bacilli: Enterobacteriaceae, Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect. 2014, 20, 831–838. [Google Scholar] [CrossRef] [Green Version]
- Leiros, H.-K.S.; Skagseth, S.; Edvardsen, K.S.W.; Lorentzen, M.S.; Bjerga, G.E.K.; Leiros, I.; Samuelsen, Ø. His224 alters the R2 drug binding site and Phe218 influences the catalytic efficiency of the metallo-β-lactamase VIM-7. Antimicrob. Agents Chemother. 2014, 58, 4826–4836. [Google Scholar] [CrossRef] [Green Version]
- Cornaglia, G.; Riccio, M.L.; Mazzariol, A.; Lauretti, L.; Fontana, R.; Rossolini, G.M. Appearance of IMP-1 metallo-beta-lactamase in Europe. Lancet Lond. Engl. 1999, 353, 899–900. [Google Scholar] [CrossRef]
- Riccio, M.L.; Franceschini, N.; Boschi, L.; Caravelli, B.; Cornaglia, G.; Fontana, R.; Amicosante, G.; Rossolini, G.M. Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allelic variants carried by gene cassettes of different phylogeny. Antimicrob. Agents Chemother. 2000, 44, 1229–1235. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Limbago, B.M.; Rasheed, J.K.; Anderson, K.F.; Zhu, W.; Kitchel, B.; Watz, N.; Munro, S.; Gans, H.; Banaei, N.; Kallen, A.J. IMP-producing carbapenem-resistant Klebsiella pneumoniae in the United States. J. Clin. Microbiol. 2011, 49, 4239–4245. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hammoudi Halat, D.; Moubareck, C.A.; Sarkis, D.K. Heterogeneity of Carbapenem Resistance Mechanisms among Gram-Negative Pathogens in Lebanon: Results of the First Cross-Sectional Countrywide Study. Microb. Drug Resist. Larchmt. N 2017, 23, 733–743. [Google Scholar] [CrossRef] [PubMed]
- McCarthy, K.L.; Jennison, A.; Wailan, A.M.; Paterson, D.L. Draft Genome Sequence of an IMP-7-Producing Pseudomonas aeruginosa Bloodstream Infection Isolate from Australia. Genome Announc. 2017, 5, e00596-17. [Google Scholar] [CrossRef] [Green Version]
- Abraham, S.; O’Dea, M.; Trott, D.J.; Abraham, R.J.; Hughes, D.; Pang, S.; McKew, G.; Cheong, E.Y.L.; Merlino, J.; Saputra, S.; et al. Isolation and plasmid characterization of carbapenemase (IMP-4) producing Salmonella enterica Typhimurium from cats. Sci. Rep. 2016, 6, 35527. [Google Scholar] [CrossRef]
- Mollenkopf, D.F.; Stull, J.W.; Mathys, D.A.; Bowman, A.S.; Feicht, S.M.; Grooters, S.V.; Daniels, J.B.; Wittum, T.E. Carbapenemase-Producing Enterobacteriaceae Recovered from the Environment of a Swine Farrow-to-Finish Operation in the United States. Antimicrob. Agents Chemother. 2017, 61, e01298-16. [Google Scholar] [CrossRef] [Green Version]
- Poirel, L.; Naas, T.; Nicolas, D.; Collet, L.; Bellais, S.; Cavallo, J.D.; Nordmann, P. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 2000, 44, 891–897. [Google Scholar] [CrossRef] [Green Version]
- Mojica, M.F.; Bonomo, R.A.; Fast, W. B1-Metallo-β-Lactamases: Where Do We Stand? Curr. Drug Targets 2016, 17, 1029–1050. [Google Scholar] [CrossRef]
- Toleman, M.A.; Rolston, K.; Jones, R.N.; Walsh, T.R. blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States. Antimicrob. Agents Chemother. 2004, 48, 329–332. [Google Scholar] [CrossRef] [Green Version]
- Balero de Paula, S.; Cayô, R.; Streling, A.P.; Silva Nodari, C.; Pereira Matos, A.; Eches Perugini, M.R.; Gales, A.C.; Carrara-Marroni, F.E.; Yamada-Ogatta, S.F. Detection of blaVIM-7 in an extensively drug-resistant Pseudomonas aeruginosa isolate belonging to ST1284 in Brazil. Diagn. Microbiol. Infect. Dis. 2017, 89, 80–82. [Google Scholar] [CrossRef]
- Carattoli, A. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 2009, 53, 2227–2238. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhang, H.; Hao, Q. Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism. J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2011, 25, 2574–2582. [Google Scholar] [CrossRef] [PubMed]
- Khan, A.U.; Nordmann, P. Spread of carbapenemase NDM-1 producers: The situation in India and what may be proposed. Scand. J. Infect. Dis. 2012, 44, 531–535. [Google Scholar] [CrossRef] [PubMed]
- Wu, W.; Feng, Y.; Tang, G.; Qiao, F.; McNally, A.; Zong, Z. NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings. Clin. Microbiol. Rev. 2019, 32, e00115-18. [Google Scholar] [CrossRef] [Green Version]
- Poirel, L.; Hombrouck-Alet, C.; Freneaux, C.; Bernabeu, S.; Nordmann, P. Global spread of New Delhi metallo-β-lactamase 1. Lancet Infect. Dis. 2010, 10, 832. [Google Scholar] [CrossRef]
- Moghadampour, M.; Salari-Jazi, A.; Faghri, J. High rate of carbapenem-resistant Klebsiella pneumoniae detected from hospital equipments in Iran. Acta Microbiol. Immunol. Hung. 2018, 65, 529–538. [Google Scholar] [CrossRef] [Green Version]
- Le Terrier, C.; Masseron, A.; Uwaezuoke, N.S.; Edwin, C.P.; Ekuma, A.E.; Olugbeminiyi, F.; Shettima, S.; Ushi, S.; Poirel, L.; Nordmann, P. Wide spread of carbapenemase producers in a Nigerian environment. J. Glob. Antimicrob. Resist. 2019. [Google Scholar] [CrossRef]
- Tang, B.; Chang, J.; Cao, L.; Luo, Q.; Xu, H.; Lyu, W.; Qian, M.; Ji, X.; Zhang, Q.; Xia, X.; et al. Characterization of an NDM-5 carbapenemase-producing Escherichia coli ST156 isolate from a poultry farm in Zhejiang, China. BMC Microbiol. 2019, 19, 82. [Google Scholar] [CrossRef] [Green Version]
- Rafei, R.; Dabboussi, F.; Hamze, M.; Eveillard, M.; Lemarié, C.; Mallat, H.; Rolain, J.-M.; Joly-Guillou, M.-L.; Kempf, M. First report of blaNDM-1-producing Acinetobacter baumannii isolated in Lebanon from civilians wounded during the Syrian war. Int. J. Infect. Dis. 2014, 21, 21–23. [Google Scholar] [CrossRef] [Green Version]
- Kaase, M.; Nordmann, P.; Wichelhaus, T.A.; Gatermann, S.G.; Bonnin, R.A.; Poirel, L. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J. Antimicrob. Chemother. 2011, 66, 1260–1262. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tada, T.; Miyoshi-Akiyama, T.; Shimada, K.; Kirikae, T. Biochemical analysis of metallo-β-lactamase NDM-3 from a multidrug-resistant Escherichia coli strain isolated in Japan. Antimicrob. Agents Chemother. 2014, 58, 3538–3540. [Google Scholar] [CrossRef] [Green Version]
- Nordmann, P.; Boulanger, A.E.; Poirel, L. NDM-4 metallo-β-lactamase with increased carbapenemase activity from Escherichia coli. Antimicrob. Agents Chemother. 2012, 56, 2184–2186. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hornsey, M.; Phee, L.; Wareham, D.W. A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob. Agents Chemother. 2011, 55, 5952–5954. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dortet, L.; Jousset, A.; Sainte-Rose, V.; Cuzon, G.; Naas, T. Prospective evaluation of the OXA-48 K-SeT assay, an immunochromatographic test for the rapid detection of OXA-48-type carbapenemases. J. Antimicrob. Chemother. 2016, 71, 1834–1840. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Greissl, C.; Saleh, A.; Hamprecht, A. Rapid detection of OXA-48-like, KPC, NDM, and VIM carbapenemases in Enterobacterales by a new multiplex immunochromatographic test. Eur. J. Clin. Microbiol. Infect. Dis. 2019, 38, 331–335. [Google Scholar] [CrossRef] [PubMed]
- Tamma, P.D.; Simner, P.J. Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates. J. Clin. Microbiol. 2018, 56, e01140-18. [Google Scholar] [CrossRef] [Green Version]
- Toleman, M.A.; Simm, A.M.; Murphy, T.A.; Gales, A.C.; Biedenbach, D.J.; Jones, R.N.; Walsh, T.R. Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: Report from the SENTRY antimicrobial surveillance programme. J. Antimicrob. Chemother. 2002, 50, 673–679. [Google Scholar] [CrossRef]
- Cacci, L.C.; Chuster, S.G.; Martins, N.; Do Carmo, P.R.; De Carvalho Girão, V.B.; Nouér, S.A.; De Freitas, W.V.; De Matos, J.A.; De Gouveia Magalhães, A.C.; Pires Ferreira, A.L.; et al. Mechanisms of carbapenem resistance in endemic Pseudomonas aeruginosa isolates after an SPM-1 metallo-β-lactamase producing strain subsided in an intensive care unit of a teaching hospital in Brazil. Mem. Inst. Oswaldo Cruz 2016, 111, 551–558. [Google Scholar]
- Nascimento, A.P.B.; Ortiz, M.F.; Martins, W.M.B.S.; Morais, G.L.; Fehlberg, L.C.C.; Almeida, L.G.P.; Ciapina, L.P.; Gales, A.C.; Vasconcelos, A.T.R. Intraclonal Genome Stability of the Metallo-β-lactamase SPM-1-producing Pseudomonas aeruginosa ST277, an Endemic Clone Disseminated in Brazilian Hospitals. Front. Microbiol. 2016, 7, 1946. [Google Scholar] [CrossRef] [Green Version]
- Chaves, L.; Tomich, L.M.; Salomão, M.; Leite, G.C.; Ramos, J.; Martins, R.R.; Rizek, C.; Neves, P.; Batista, M.V.; Amigo, U.; et al. High mortality of bloodstream infection outbreak caused by carbapenem-resistant P. aeruginosa producing SPM-1 in a bone marrow transplant unit. J. Med. Microbiol. 2017, 66, 1722–1729. [Google Scholar] [CrossRef]
- Martins, W.M.B.S.; Narciso, A.C.; Cayô, R.; Santos, S.V.; Fehlberg, L.C.C.; Ramos, P.L.; Da Cruz, J.B.; Gales, A.C. SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds. Diagn. Microbiol. Infect. Dis. 2018, 90, 221–227. [Google Scholar] [CrossRef] [PubMed]
- Hopkins, K.L.; Meunier, D.; Findlay, J.; Mustafa, N.; Parsons, H.; Pike, R.; Wright, L.; Woodford, N. SPM-1 metallo-β-lactamase-producing Pseudomonas aeruginosa ST277 in the UK. J. Med. Microbiol. 2016, 65, 696–697. [Google Scholar] [CrossRef] [PubMed]
- Salabi, A.E.; Toleman, M.A.; Weeks, J.; Bruderer, T.; Frei, R.; Walsh, T.R. First report of the metallo-beta-lactamase SPM-1 in Europe. Antimicrob. Agents Chemother. 2010, 54, 582. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shahcheraghi, F.; Abbasalipour, M.; Feizabadi, M.; Ebrahimipour, G.; Akbari, N. Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran. J. Microbiol. 2011, 3, 68–74. [Google Scholar]
- Andrade, L.N.; Woodford, N.; Darini, A.L.C. International gatherings and potential for global dissemination of São Paulo metallo-β-lactamase (SPM) from Brazil. Int. J. Antimicrob. Agents 2014, 43, 196–197. [Google Scholar] [CrossRef]
- Toleman, M.A.; Bennett, P.M.; Walsh, T.R. ISCR elements: Novel gene-capturing systems of the 21st century? Microbiol. Mol. Biol. Rev. 2006, 70, 296–316. [Google Scholar] [CrossRef] [Green Version]
- Zhao, W.-H.; Hu, Z.-Q. Acquired metallo-β-lactamases and their genetic association with class 1 integrons and ISCR elements in Gram-negative bacteria. Future Microbiol. 2015, 10, 873–887. [Google Scholar] [CrossRef]
- Castanheira, M.; Toleman, M.A.; Jones, R.N.; Schmidt, F.J.; Walsh, T.R. Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase. Antimicrob. Agents Chemother. 2004, 48, 4654–4661. [Google Scholar] [CrossRef] [Green Version]
- Girija, S.A.; Jayaseelan, V.P.; Arumugam, P. Prevalence of VIM- and GIM-producing Acinetobacter baumannii from patients with severe urinary tract infection. Acta Microbiol. Immunol. Hung. 2018, 65, 539–550. [Google Scholar] [CrossRef] [Green Version]
- Lee, K.; Yum, J.H.; Yong, D.; Lee, H.M.; Kim, H.D.; Docquier, J.-D.; Rossolini, G.M.; Chong, Y. Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother. 2005, 49, 4485–4491. [Google Scholar] [CrossRef] [Green Version]
- Lü, Y.; Zhao, S.; Liang, H.; Zhang, W.; Liu, J.; Hu, H. The first report of a novel IncHI1B blaSIM-1-carrying megaplasmid pSIM-1-BJ01 from a clinical Klebsiella pneumoniae isolate. Infect. Drug Resist. 2019, 12, 2103–2112. [Google Scholar] [CrossRef] [Green Version]
- Poirel, L.; Rodríguez-Martínez, J.-M.; Al Naiemi, N.; Debets-Ossenkopp, Y.J.; Nordmann, P. Characterization of DIM-1, an integron-encoded metallo-beta-lactamase from a Pseudomonas stutzeri clinical isolate in The Netherlands. Antimicrob. Agents Chemother. 2010, 54, 2420–2424. [Google Scholar] [CrossRef] [Green Version]
- Sekiguchi, J.; Morita, K.; Kitao, T.; Watanabe, N.; Okazaki, M.; Miyoshi-Akiyama, T.; Kanamori, M.; Kirikae, T. KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate. Antimicrob. Agents Chemother. 2008, 52, 4194–4197. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Skagseth, S.; Christopeit, T.; Akhter, S.; Bayer, A.; Samuelsen, Ø.; Leiros, H.-K.S. Structural Insights into TMB-1 and the Role of Residues 119 and 228 in Substrate and Inhibitor Binding. Antimicrob. Agents Chemother. 2017, 61, e02602-16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Evans, B.A.; Amyes, S.G.B. OXA β-lactamases. Clin. Microbiol. Rev. 2014, 27, 241–263. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Walther-Rasmussen, J.; Høiby, N. Class A carbapenemases. J. Antimicrob. Chemother. 2007, 60, 470–482. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sykes, R.B.; Matthew, M. The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics. J. Antimicrob. Chemother. 1976, 2, 115–157. [Google Scholar] [CrossRef]
- Hall, L.M.; Livermore, D.M.; Gur, D.; Akova, M.; Akalin, H.E. OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 1993, 37, 1637–1644. [Google Scholar] [CrossRef] [Green Version]
- Poirel, L.; Figueiredo, S.; Cattoir, V.; Carattoli, A.; Nordmann, P. Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob. Agents Chemother. 2008, 52, 1252–1256. [Google Scholar] [CrossRef] [Green Version]
- Kaitany, K.-C.J.; Klinger, N.V.; June, C.M.; Ramey, M.E.; Bonomo, R.A.; Powers, R.A.; Leonard, D.A. Structures of the class D Carbapenemases OXA-23 and OXA-146: Mechanistic basis of activity against carbapenems, extended-spectrum cephalosporins, and aztreonam. Antimicrob. Agents Chemother. 2013, 57, 4848–4855. [Google Scholar] [CrossRef] [Green Version]
- Smith, C.A.; Antunes, N.T.; Stewart, N.K.; Toth, M.; Kumarasiri, M.; Chang, M.; Mobashery, S.; Vakulenko, S.B. Structural basis for carbapenemase activity of the OXA-23 β-lactamase from Acinetobacter baumannii. Chem. Biol. 2013, 20, 1107–1115. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Corvec, S.; Poirel, L.; Naas, T.; Drugeon, H.; Nordmann, P. Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob. Agents Chemother. 2007, 51, 1530–1533. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jiang, L.; Liang, Y.; Yao, W.; Ai, J.; Wang, X.; Zhao, Z. Molecular epidemiology and genetic characterisation of carbapenem-resistant Acinetobacter baumannii isolates from Guangdong Province, South China. J. Glob. Antimicrob. Resist. 2019, 17, 84–89. [Google Scholar] [CrossRef] [PubMed]
- Liu, L.-L.; Ji, S.-J.; Ruan, Z.; Fu, Y.; Fu, Y.-Q.; Wang, Y.-F.; Yu, Y.-S. Dissemination of blaOXA-23 in Acinetobacter spp. in China: Main roles of conjugative plasmid pAZJ221 and transposon Tn2009. Antimicrob. Agents Chemother. 2015, 59, 1998–2005. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Turton, J.F.; Ward, M.E.; Woodford, N.; Kaufmann, M.E.; Pike, R.; Livermore, D.M.; Pitt, T.L. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 2006, 258, 72–77. [Google Scholar] [CrossRef] [Green Version]
- Schultz, M.B.; Pham Thanh, D.; Tran Do Hoan, N.; Wick, R.R.; Ingle, D.J.; Hawkey, J.; Edwards, D.J.; Kenyon, J.J.; Phu Huong Lan, N.; Campbell, J.I.; et al. Repeated local emergence of carbapenem-resistant Acinetobacter baumannii in a single hospital ward. Microb. Genom. 2016, 2, e000050. [Google Scholar] [CrossRef]
- Bou, G.; Oliver, A.; Martínez-Beltrán, J. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob. Agents Chemother. 2000, 44, 1556–1561. [Google Scholar] [CrossRef] [Green Version]
- Kuo, S.-C.; Huang, W.-C.; Huang, T.-W.; Wang, H.-Y.; Lai, J.-F.; Chen, T.-L.; Lauderdale, T.-L. Molecular Epidemiology of Emerging blaOXA-23-Like- and blaOXA-24-Like-Carrying Acinetobacter baumannii in Taiwan. Antimicrob. Agents Chemother. 2018, 62, e01215-17. [Google Scholar] [CrossRef] [Green Version]
- Leungtongkam, U.; Thummeepak, R.; Wongprachan, S.; Thongsuk, P.; Kitti, T.; Ketwong, K.; Runcharoen, C.; Chantratita, N.; Sitthisak, S. Dissemination of blaOXA-23, blaOXA-24, blaOXA-58, and blaNDM-1 Genes of Acinetobacter baumannii Isolates from Four Tertiary Hospitals in Thailand. Microb. Drug Resist. Larchmt. N 2018, 24, 55–62. [Google Scholar] [CrossRef]
- Todorova, B.; Velinov, T.; Ivanov, I.; Dobreva, E.; Kantardjiev, T. First detection of OXA-24 carbapenemase-producing Acinetobacter baumannii isolates in Bulgaria. World J. Microbiol. Biotechnol. 2014, 30, 1427–1430. [Google Scholar] [CrossRef]
- Hammoudi, D.; Moubareck, C.A.; Hakime, N.; Houmani, M.; Barakat, A.; Najjar, Z.; Suleiman, M.; Fayad, N.; Sarraf, R.; Sarkis, D.K. Spread of imipenem-resistant Acinetobacter baumannii co-expressing OXA-23 and GES-11 carbapenemases in Lebanon. Int. J. Infect. Dis. 2015, 36, 56–61. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sevillano, E.; Valderrey, C.; Canduela, M.J.; Umaran, A.; Calvo, F.; Gallego, L. Resistance to antibiotics in clinical isolates of Pseudomonas aeruginosa. Pathol. Biol. 2006, 54, 493–497. [Google Scholar] [CrossRef] [PubMed]
- Pailhoriès, H.; Kempf, M.; Belmonte, O.; Joly-Guillou, M.-L.; Eveillard, M. First case of OXA-24-producing Acinetobacter baumannii in cattle from Reunion Island, France. Int. J. Antimicrob. Agents 2016, 48, 763–764. [Google Scholar] [CrossRef] [PubMed]
- Klotz, P.; Jacobmeyer, L.; Stamm, I.; Leidner, U.; Pfeifer, Y.; Semmler, T.; Prenger-Berninghoff, E.; Ewers, C. Carbapenem-resistant Acinetobacter baumannii ST294 harbouring the OXA-72 carbapenemase from a captive grey parrot. J. Antimicrob. Chemother. 2018, 73, 1098–1100. [Google Scholar] [CrossRef] [PubMed]
- Poirel, L.; Marqué, S.; Héritier, C.; Segonds, C.; Chabanon, G.; Nordmann, P. OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 2005, 49, 202–208. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Salehi, B.; Ghalavand, Z.; Mohammadzadeh, M.; Maleki, D.T.; Kodori, M.; Kadkhoda, H. Clonal relatedness and resistance characteristics of OXA-24 and -58 producing carbapenem-resistant Acinetobacter baumannii isolates in Tehran, Iran. J. Appl. Microbiol. 2019, 127, 1421–1429. [Google Scholar] [CrossRef] [PubMed]
- Karampatakis, T.; Tsergouli, K.; Politi, L.; Diamantopoulou, G.; Iosifidis, E.; Antachopoulos, C.; Karyoti, A.; Sdougka, M.; Tsakris, A.; Roilides, E. Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit. Mol. Biol. Rep. 2019, 46, 3497–3500. [Google Scholar] [CrossRef]
- Cameranesi, M.M.; Morán-Barrio, J.; Limansky, A.S.; Repizo, G.D.; Viale, A.M. Site-Specific Recombination at XerC/D Sites Mediates the Formation and Resolution of Plasmid Co-integrates Carrying a blaOXA-58- and TnaphA6-Resistance Module in Acinetobacter baumannii. Front. Microbiol. 2018, 9, 66. [Google Scholar] [CrossRef] [Green Version]
- Zarrilli, R.; Vitale, D.; Di Popolo, A.; Bagattini, M.; Daoud, Z.; Khan, A.U.; Afif, C.; Triassi, M. A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital. Antimicrob. Agents Chemother. 2008, 52, 4115–4120. [Google Scholar] [CrossRef] [Green Version]
- Girlich, D.; Bonnin, R.A.; Bogaerts, P.; De Laveleye, M.; Huang, D.T.; Dortet, L.; Glaser, P.; Glupczynski, Y.; Naas, T. Chromosomal Amplification of the blaOXA-58 Carbapenemase Gene in a Proteus mirabilis Clinical Isolate. Antimicrob. Agents Chemother. 2017, 61, e01697-16. [Google Scholar] [CrossRef] [Green Version]
- Lange, F.; Pfennigwerth, N.; Gerigk, S.; Gohlke, F.; Oberdorfer, K.; Purr, I.; Wohanka, N.; Roggenkamp, A.; Gatermann, S.G.; Kaase, M. Dissemination of blaOXA-58 in Proteus mirabilis isolates from Germany. J. Antimicrob. Chemother. 2017, 72, 1334–1339. [Google Scholar] [PubMed] [Green Version]
- Literacka, E.; Izdebski, R.; Baraniak, A.; Żabicka, D.; Schneider, A.; Urbanowicz, P.; Herda, M.; Hryniewicz, W.; Gniadkowski, M. Proteus mirabilis Producing the OXA-58 Carbapenemase in Poland. Antimicrob. Agents Chemother. 2019, 63, AAC-00106. [Google Scholar] [CrossRef] [Green Version]
- Chen, Y.; Guo, P.; Huang, H.; Huang, Y.; Wu, Z.; Liao, K. Detection of co-harboring OXA-58 and NDM-1 carbapenemase producing genes resided on a same plasmid from an Acinetobacter pittii clinical isolate in China. Iran. J. Basic Med. Sci. 2019, 22, 106–111. [Google Scholar] [PubMed]
- Jiang, N.; Zhang, X.; Zhou, Y.; Zhang, Z.; Zheng, X. Whole-genome sequencing of an NDM-1- and OXA-58-producing Acinetobacter towneri isolate from hospital sewage in Sichuan Province, China. J. Glob. Antimicrob. Resist. 2019, 16, 4–5. [Google Scholar] [CrossRef] [PubMed]
- Xin, R.; Zhang, K.; Wu, N.; Zhang, Y.; Niu, Z. The pollution level of the blaOXA-58 carbapenemase gene in coastal water and its host bacteria characteristics. Environ. Pollut. 2019, 244, 66–71. [Google Scholar] [CrossRef] [PubMed]
- Higgins, P.G.; Poirel, L.; Lehmann, M.; Nordmann, P.; Seifert, H. OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 2009, 53, 5035–5038. [Google Scholar] [CrossRef] [Green Version]
- Neves, F.C.; Clemente, W.T.; Lincopan, N.; Paião, I.D.; Neves, P.R.; Romanelli, R.M.; Lima, S.S.S.; Paiva, L.F.; Mourão, P.H.O.; Nobre-Junior, V.A. Clinical and microbiological characteristics of OXA-23- and OXA-143-producing Acinetobacter baumannii in ICU patients at a teaching hospital, Brazil. Braz. J. Infect. Dis. 2016, 20, 556–563. [Google Scholar] [CrossRef] [Green Version]
- Dias, V.C.; Resende, J.A.; Bastos, A.N.; De Andrade Bastos, L.Q.; De Andrade Bastos, V.Q.; Bastos, R.V.; Diniz, C.G.; Da Silva, V.L. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Microb. Drug Resist. Larchmt. N 2017, 23, 852–863. [Google Scholar] [CrossRef]
- Sarikhani, Z.; Nazari, R.; Nateghi Rostami, M. First report of OXA-143-lactamase producing Acinetobacter baumannii in Qom, Iran. Iran. J. Basic Med. Sci. 2017, 20, 1282–1286. [Google Scholar]
- Gionco, B.; Pelayo, J.S.; Venancio, E.J.; Cayô, R.; Gales, A.C.; Carrara-Marroni, F.E. Detection of OXA-231, a new variant of blaOXA-143, in Acinetobacter baumannii from Brazil: A case report. J. Antimicrob. Chemother. 2012, 67, 2531–2532. [Google Scholar] [CrossRef] [Green Version]
- Higgins, P.G.; Pérez-Llarena, F.J.; Zander, E.; Fernández, A.; Bou, G.; Seifert, H. OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 2013, 57, 2121–2126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Boyd, D.A.; Mataseje, L.F.; Pelude, L.; Mitchell, R.; Bryce, E.; Roscoe, D.; Embree, J.; Katz, K.; Kibsey, P.; Lavallee, C.; et al. Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp. in Canadian hospitals, 2010–2016. J. Antimicrob. Chemother. 2019, 74, 315–320. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ng, C.; Tan, B.; Jiang, X.-T.; Gu, X.; Chen, H.; Schmitz, B.W.; Haller, L.; Charles, F.R.; Zhang, T.; Gin, K. Metagenomic and Resistome Analysis of a Full-Scale Municipal Wastewater Treatment Plant in Singapore Containing Membrane Bioreactors. Front. Microbiol. 2019, 10, 172. [Google Scholar] [CrossRef] [PubMed]
- Carrër, A.; Poirel, L.; Eraksoy, H.; Cagatay, A.A.; Badur, S.; Nordmann, P. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob. Agents Chemother. 2008, 52, 2950–2954. [Google Scholar] [CrossRef] [Green Version]
- Poirel, L.; Bonnin, R.A.; Nordmann, P. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob. Agents Chemother. 2012, 56, 559–562. [Google Scholar] [CrossRef] [Green Version]
- Turton, J.F.; Doumith, M.; Hopkins, K.L.; Perry, C.; Meunier, D.; Woodford, N. Clonal expansion of Escherichia coli ST38 carrying a chromosomally integrated OXA-48 carbapenemase gene. J. Med. Microbiol. 2016, 65, 538–546. [Google Scholar] [CrossRef]
- Poirel, L.; Abdelaziz, M.O.; Bernabeu, S.; Nordmann, P. Occurrence of OXA-48 and VIM-1 carbapenemase-producing Enterobacteriaceae in Egypt. Int. J. Antimicrob. Agents 2013, 41, 90–91. [Google Scholar] [CrossRef]
- Pitout, J.D.D.; Peirano, G.; Kock, M.M.; Strydom, K.-A.; Matsumura, Y. The Global Ascendency of OXA-48-Type Carbapenemases. Clin. Microbiol. Rev. 2019, 33. [Google Scholar] [CrossRef]
- Potron, A.; Nordmann, P.; Lafeuille, E.; Al Maskari, Z.; Al Rashdi, F.; Poirel, L. Characterization of OXA-181, a carbapenem-hydrolyzing class D beta-lactamase from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2011, 55, 4896–4899. [Google Scholar] [CrossRef] [Green Version]
- Messaoudi, A.; Saras, E.; Grami, R.; Bouallègue, O.; Boujâafar, N.; Madec, J.-Y.; Mansour, W.; Haenni, M. Emergence of OXA-204 carbapenemase in Enterobacter cloacae. Int. J. Antimicrob. Agents 2019, 54, 829–830. [Google Scholar] [CrossRef]
- Sghaier, S.; Abbassi, M.S.; Pascual, A.; Serrano, L.; Díaz-De-Alba, P.; Said, M.B.; Hassen, B.; Ibrahim, C.; Hassen, A.; López-Cerero, L. Extended-spectrum β-lactamase-producing Enterobacteriaceae from animal origin and wastewater in Tunisia: First detection of O25b-B23-CTX-M-27-ST131 Escherichia coli and CTX-M-15/OXA-204-producing Citrobacter freundii from wastewater. J. Glob. Antimicrob. Resist. 2019, 17, 189–194. [Google Scholar] [CrossRef] [PubMed]
- Darwich, L.; Vidal, A.; Seminati, C.; Albamonte, A.; Casado, A.; López, F.; Molina-López, R.A.; Migura-Garcia, L. High prevalence and diversity of extended-spectrum β-lactamase and emergence of OXA-48 producing Enterobacterales in wildlife in Catalonia. PLoS ONE 2019, 14, e0210686. [Google Scholar] [CrossRef] [Green Version]
- Pulss, S.; Stolle, I.; Stamm, I.; Leidner, U.; Heydel, C.; Semmler, T.; Prenger-Berninghoff, E.; Ewers, C. Multispecies and Clonal Dissemination of OXA-48 Carbapenemase in Enterobacteriaceae From Companion Animals in Germany, 2009–2016. Front. Microbiol. 2018, 9, 1265. [Google Scholar] [CrossRef] [PubMed]
- Bae, D.-W.; Jung, Y.-E.; An, Y.J.; Na, J.-H.; Cha, S.-S. Structural Insights into Catalytic Relevances of Substrate Poses in ACC-1. Antimicrob. Agents Chemother. 2019, 63, e01411-19. [Google Scholar] [CrossRef] [PubMed]
- Mammeri, H.; Guillon, H.; Eb, F.; Nordmann, P. Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases. Antimicrob. Agents Chemother. 2010, 54, 4556–4560. [Google Scholar] [CrossRef] [Green Version]
- Koyano, S.; Saito, R.; Nagai, R.; Tatsuno, K.; Okugawa, S.; Okamura, N.; Moriya, K. Molecular characterization of carbapenemase-producing clinical isolates of Enterobacteriaceae in a teaching hospital, Japan. J. Med. Microbiol. 2013, 62, 446–450. [Google Scholar] [CrossRef] [Green Version]
- Jousset, A.B.; Oueslati, S.; Bernabeu, S.; Takissian, J.; Creton, E.; Vogel, A.; Sauvadet, A.; Cotellon, G.; Gauthier, L.; Bonnin, R.A.; et al. False-Positive Carbapenem-Hydrolyzing Confirmatory Tests Due to ACT-28, a Chromosomally Encoded AmpC with Weak Carbapenemase Activity from Enterobacter kobei. Antimicrob. Agents Chemother. 2019, 63, e02388-18. [Google Scholar] [CrossRef] [Green Version]
- Kim, J.Y.; Jung, H.I.; An, Y.J.; Lee, J.H.; Kim, S.J.; Jeong, S.H.; Lee, K.J.; Suh, P.-G.; Lee, H.-S.; Lee, S.H.; et al. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase. Mol. Microbiol. 2006, 60, 907–916. [Google Scholar] [CrossRef]
- Jeon, J.H.; Hong, M.K.; Lee, J.H.; Lee, J.J.; Park, K.S.; Karim, A.M.; Jo, J.Y.; Kim, J.H.; Ko, K.S.; Kang, L.W.; et al. Structure of ADC-68, a novel carbapenem-hydrolyzing class C extended-spectrum β-lactamase isolated from Acinetobacter baumannii. Acta Crystallogr. D Biol. Crystallogr. 2014, 70, 2924–2936. [Google Scholar] [CrossRef]
- Rood, I.G.H.; Li, Q. Review: Molecular detection of extended spectrum-β-lactamase- and carbapenemase-producing Enterobacteriaceae in a clinical setting. Diagn. Microbiol. Infect. Dis. 2017, 89, 245–250. [Google Scholar] [CrossRef]
- Livermore, D.M.; Woodford, N. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 2006, 14, 413–420. [Google Scholar] [CrossRef] [PubMed]
- Durante-Mangoni, E.; Andini, R.; Zampino, R. Management of carbapenem-resistant Enterobacteriaceae infections. Clin. Microbiol. Infect. 2019, 25, 943–950. [Google Scholar] [CrossRef] [PubMed]
- Moxon, C.A.; Paulus, S. Beta-lactamases in Enterobacteriaceae infections in children. J. Infect. 2016, 72, S41–S49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zafer, M.M.; El-Mahallawy, H.A.; Abdulhak, A.; Amin, M.A.; Al-Agamy, M.H.; Radwan, H.H. Emergence of colistin resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli strains isolated from cancer patients. Ann. Clin. Microbiol. Antimicrob. 2019, 18, 40. [Google Scholar] [CrossRef] [PubMed]
- Ni, W.; Han, Y.; Liu, J.; Wei, C.; Zhao, J.; Cui, J.; Wang, R.; Liu, Y. Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis. Medicine 2016, 95, e3126. [Google Scholar] [CrossRef]
- Sheu, C.-C.; Chang, Y.-T.; Lin, S.-Y.; Chen, Y.-H.; Hsueh, P.-R. Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options. Front. Microbiol. 2019, 10, 80. [Google Scholar] [CrossRef] [Green Version]
- Nordmann, P. Carbapenemase-producing Enterobacteriaceae: Overview of a major public health challenge. Med. Mal. Infect. 2014, 44, 51–56. [Google Scholar] [CrossRef] [Green Version]
- Suay-García, B.; Pérez-Gracia, M.T. Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections. Antibiotics 2019, 8, 122. [Google Scholar] [CrossRef] [Green Version]
- Rosa, J.F.; Rizek, C.; Marchi, A.P.; Guimaraes, T.; Miranda, L.; Carrilho, C.; Levin, A.S.; Costa, S.F. Clonality, outer-membrane proteins profile and efflux pump in KPC- producing Enterobacter sp. in Brazil. BMC Microbiol. 2017, 17, 69. [Google Scholar] [CrossRef] [Green Version]
- Pal, A.; Dhara, L.; Tripathi, A. Contribution of acrB upregulation & OmpC/Ompk36 loss over the presence of blaNDM towards carbapenem resistance development among pathogenic Escherichia coli & Klebsiella spp. Indian J. Med. Res. 2019, 149, 528–538. [Google Scholar]
- Chiu, S.-K.; Chan, M.-C.; Huang, L.-Y.; Lin, Y.-T.; Lin, J.-C.; Lu, P.-L.; Siu, L.K.; Chang, F.-Y.; Yeh, K.-M. Tigecycline resistance among carbapenem-resistant Klebsiella pneumoniae: Clinical characteristics and expression levels of efflux pump genes. PLoS ONE 2017, 12, e0175140. [Google Scholar] [CrossRef] [PubMed]
- Ma, P.; Laibinis, H.H.; Ernst, C.M.; Hung, D.T. Carbapenem Resistance Caused by High-Level Expression of OXA-663 β-Lactamase in an OmpK36-Deficient Klebsiella pneumoniae Clinical Isolate. Antimicrob. Agents Chemother. 2018, 62, e01281-18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hamzaoui, Z.; Ocampo-Sosa, A.; Fernandez Martinez, M.; Landolsi, S.; Ferjani, S.; Maamar, E.; Saidani, M.; Slim, A.; Martinez-Martinez, L.; Boutiba-Ben Boubaker, I. Role of association of OmpK35 and OmpK36 alteration and blaESBL and/or blaAmpC genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae. Int. J. Antimicrob. Agents 2018, 52, 898–905. [Google Scholar] [CrossRef]
- Chang, Y.-T.; Siu, L.K.; Wang, J.-T.; Wu, T.-L.; Chen, Y.-H.; Chuang, Y.-C.; Lin, J.-C.; Lu, P.-L. Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012–2015. Infect. Drug Resist. 2019, 12, 2113–2123. [Google Scholar] [CrossRef] [Green Version]
- Cantón, R.; Akóva, M.; Carmeli, Y.; Giske, C.G.; Glupczynski, Y.; Gniadkowski, M.; Livermore, D.M.; Miriagou, V.; Naas, T.; Rossolini, G.M.; et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 2012, 18, 413–431. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Guo, X.; Rao, Y.; Guo, L.; Xu, H.; Lv, T.; Yu, X.; Chen, Y.; Liu, N.; Han, H.; Zheng, B. Detection and Genomic Characterization of a Morganella morganii Isolate from China That Produces NDM-5. Front. Microbiol. 2019, 10, 1156. [Google Scholar] [CrossRef]
- Moura, Q.; Cerdeira, L.; Fernandes, M.R.; Vianello, M.A.; Lincopan, N. Novel class 1 integron (In1390) harboring blaGES-5 in a Morganella morganii strain recovered from a remote community. Diagn. Microbiol. Infect. Dis. 2018, 91, 345–347. [Google Scholar] [CrossRef] [PubMed]
- Albiger, B.; Glasner, C.; Struelens, M.J.; Grundmann, H.; Monnet, D.L. European Survey of Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group Carbapenemase-producing Enterobacteriaceae in Europe: Assessment by national experts from 38 countries, May 2015. Eurosurveillance 2015, 20, 30062. [Google Scholar] [CrossRef] [Green Version]
- Chen, L.; Mathema, B.; Chavda, K.D.; DeLeo, F.R.; Bonomo, R.A.; Kreiswirth, B.N. Carbapenemase-producing Klebsiella pneumoniae: Molecular and genetic decoding. Trends Microbiol. 2014, 22, 686–696. [Google Scholar] [CrossRef] [Green Version]
- Pitout, J.D.D.; Nordmann, P.; Poirel, L. Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance. Antimicrob. Agents Chemother. 2015, 59, 5873–5884. [Google Scholar] [CrossRef] [Green Version]
- Mathers, A.J.; Peirano, G.; Pitout, J.D.D. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin. Microbiol. Rev. 2015, 28, 565–591. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Baquero, F.; Tedim, A.P.; Coque, T.M. Antibiotic resistance shaping multi-level population biology of bacteria. Front. Microbiol. 2013, 4, 15. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Woodford, N.; Turton, J.F.; Livermore, D.M. Multiresistant Gram-negative bacteria: The role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 2011, 35, 736–755. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kitchel, B.; Rasheed, J.K.; Patel, J.B.; Srinivasan, A.; Navon-Venezia, S.; Carmeli, Y.; Brolund, A.; Giske, C.G. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: Clonal expansion of multilocus sequence type 258. Antimicrob. Agents Chemother. 2009, 53, 3365–3370. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Garza-Ramos, U.; Barrios, H.; Reyna-Flores, F.; Sánchez-Pérez, A.; Tamayo-Legorreta, E.; Ibarra-Pacheco, A.; Salazar-Salinas, J.; Núñez-Ceballos, R.; Silva-Sanchez, J. Characteristics of KPC-2-producing Klebsiella pneumoniae (ST258) clinical isolates from outbreaks in 2 Mexican medical centers. Diagn. Microbiol. Infect. Dis. 2014, 79, 483–485. [Google Scholar] [CrossRef]
- Tijet, N.; Sheth, P.M.; Lastovetska, O.; Chung, C.; Patel, S.N.; Melano, R.G. Molecular characterization of Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae in Ontario, Canada, 2008–2011. PLoS ONE 2014, 9, e116421. [Google Scholar] [CrossRef]
- Andrade, L.N.; Curiao, T.; Ferreira, J.C.; Longo, J.M.; Clímaco, E.C.; Martinez, R.; Bellissimo-Rodrigues, F.; Basile-Filho, A.; Evaristo, M.A.; Del Peloso, P.F.; et al. Dissemination of blaKPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil. Antimicrob. Agents Chemother. 2011, 55, 3579–3583. [Google Scholar] [CrossRef] [Green Version]
- Prado-Vivar, M.B.; Ortiz, L.; Reyes, J.; Villacis, E.; Fornasini, M.; Baldeon, M.E.; Cardenas, P.A. Molecular typing of a large nosocomial outbreak of KPC-producing bacteria in the biggest tertiary-care hospital of Quito, Ecuador. J. Glob. Antimicrob. Resist. 2019, 19, 328–332. [Google Scholar] [CrossRef]
- Soria-Segarra, C.; González-Bustos, P.; López-Cerero, L.; Fernández-Cuenca, F.; Rojo-Martín, M.D.; Fernández-Sierra, M.A.; Gutiérrez-Fernández, J. Tracking KPC-3-producing ST-258 Klebsiella pneumoniae outbreak in a third-level hospital in Granada (Andalusia, Spain) by risk factors and molecular characteristics. Mol. Biol. Rep. 2020, 47, 1089–1097. [Google Scholar] [CrossRef]
- Meletis, G.; Chatzopoulou, F.; Fragkouli, A.; Alexandridou, M.; Mavrovouniotis, I.; Chatzinikolaou, A.; Chatzidimitriou, D. Whole-genome sequencing study of KPC-encoding Klebsiella pneumoniae isolated in Greek private laboratories from non-hospitalised patients. J. Glob. Antimicrob. Resist. 2019, 20, 78–81. [Google Scholar] [CrossRef]
- Becker, L.; Kaase, M.; Pfeifer, Y.; Fuchs, S.; Reuss, A.; Von Laer, A.; Sin, M.A.; Korte-Berwanger, M.; Gatermann, S.; Werner, G. Genome-based analysis of Carbapenemase-producing Klebsiella pneumoniae isolates from German hospital patients, 2008–2014. Antimicrob. Resist. Infect. Control 2018, 7, 62. [Google Scholar] [CrossRef] [PubMed]
- Clemente, A.M.; Castronovo, G.; Antonelli, A.; D’Andrea, M.M.; Tanturli, M.; Perissi, E.; Paccosi, S.; Parenti, A.; Cozzolino, F.; Rossolini, G.M.; et al. Differential Th17 response induced by the two clades of the pandemic ST258 Klebsiella pneumoniae clonal lineages producing KPC-type carbapenemase. PLoS ONE 2017, 12, e0178847. [Google Scholar] [CrossRef] [PubMed]
- Samuelsen, Ø.; Naseer, U.; Tofteland, S.; Skutlaberg, D.H.; Onken, A.; Hjetland, R.; Sundsfjord, A.; Giske, C.G. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. J. Antimicrob. Chemother. 2009, 63, 654–658. [Google Scholar] [CrossRef] [PubMed]
- Yu, F.; Lv, J.; Niu, S.; Du, H.; Tang, Y.-W.; Pitout, J.D.D.; Bonomo, R.A.; Kreiswirth, B.N.; Chen, L. Multiplex PCR Analysis for Rapid Detection of Klebsiella pneumoniae Carbapenem-Resistant (Sequence Type 258 [ST258] and ST11) and Hypervirulent (ST23, ST65, ST86, and ST375) Strains. J. Clin. Microbiol. 2018, 56, e00731-18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, Y.; Kim, B.-S.; Chun, J.; Yong, J.H.; Lee, Y.S.; Yoo, J.S.; Yong, D.; Hong, S.G.; D’Souza, R.; Thomson, K.S.; et al. Clonality and Resistome analysis of KPC-producing Klebsiella pneumoniae strain isolated in Korea using whole genome sequencing. BioMed Res. Int. 2014, 2014, 352862. [Google Scholar] [CrossRef] [PubMed]
- Jelić, M.; Hrenović, J.; Dekić, S.; Goić-Barišić, I.; Tambić Andrašević, A. First evidence of KPC-producing ST258 Klebsiella pneumoniae in river water. J. Hosp. Infect. 2019, 103, 147–150. [Google Scholar] [CrossRef] [PubMed]
- Leavitt, A.; Chmelnitsky, I.; Carmeli, Y.; Navon-Venezia, S. Complete nucleotide sequence of KPC-3-encoding plasmid pKpQIL in the epidemic Klebsiella pneumoniae sequence type 258. Antimicrob. Agents Chemother. 2010, 54, 4493–4496. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chen, L.; Chavda, K.D.; Melano, R.G.; Jacobs, M.R.; Koll, B.; Hong, T.; Rojtman, A.D.; Levi, M.H.; Bonomo, R.A.; Kreiswirth, B.N. Comparative genomic analysis of KPC-encoding pKpQIL-like plasmids and their distribution in New Jersey and New York Hospitals. Antimicrob. Agents Chemother. 2014, 58, 2871–2877. [Google Scholar] [CrossRef] [Green Version]
- El Zowalaty, M.E.; Al Thani, A.A.; Webster, T.J.; El Zowalaty, A.E.; Schweizer, H.P.; Nasrallah, G.K.; Marei, H.E.; Ashour, H.M. Pseudomonas aeruginosa: Arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies. Future Microbiol. 2015, 10, 1683–1706. [Google Scholar] [CrossRef]
- Tümmler, B. Emerging therapies against infections with Pseudomonas aeruginosa. F1000Research 2019, 8. [Google Scholar] [CrossRef]
- Walters, M.S.; Grass, J.E.; Bulens, S.N.; Hancock, E.B.; Phipps, E.C.; Muleta, D.; Mounsey, J.; Kainer, M.A.; Concannon, C.; Dumyati, G.; et al. Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015. Emerg. Infect. Dis. 2019, 25, 1281–1288. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hong, D.J.; Bae, I.K.; Jang, I.-H.; Jeong, S.H.; Kang, H.-K.; Lee, K. Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa. Infect. Chemother. 2015, 47, 81–97. [Google Scholar] [CrossRef] [PubMed]
- Eichenberger, E.M.; Thaden, J.T. Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria. Antibiot. Basel Switz. 2019, 8, 37. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Potron, A.; Poirel, L.; Nordmann, P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology. Int. J. Antimicrob. Agents 2015, 45, 568–585. [Google Scholar] [CrossRef] [Green Version]
- Hong, J.S.; Choi, N.; Kim, S.J.; Choi, K.H.; Roh, K.H.; Lee, S. Molecular Characteristics of GES-Type Carbapenemase-Producing Pseudomonas aeruginosa Clinical Isolates from Long-Term Care Facilities and General Hospitals in South Korea. Microb. Drug Resist. Larchmt. N 2019. [Google Scholar] [CrossRef]
- McCracken, M.G.; Adam, H.J.; Blondeau, J.M.; Walkty, A.J.; Karlowsky, J.A.; Hoban, D.J.; Zhanel, G.G.; Mulvey, M.R. Canadian Antimicrobial Resistance Alliance (CARA) and CANWARD Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: Results of the CANWARD 2007–2016 study. J. Antimicrob. Chemother. 2019, 74, iv32–iv38. [Google Scholar] [CrossRef]
- Saharman, Y.R.; Pelegrin, A.C.; Karuniawati, A.; Sedono, R.; Aditianingsih, D.; Goessens, W.H.F.; Klaassen, C.H.W.; Van Belkum, A.; Mirande, C.; Verbrugh, H.A.; et al. Epidemiology and characterisation of carbapenem-non-susceptible Pseudomonas aeruginosa in a large intensive care unit in Jakarta, Indonesia. Int. J. Antimicrob. Agents 2019, 54, 655–660. [Google Scholar] [CrossRef]
- Hishinuma, T.; Tada, T.; Kuwahara-Arai, K.; Yamamoto, N.; Shimojima, M.; Kirikae, T. Spread of GES-5 carbapenemase-producing Pseudomonas aeruginosa clinical isolates in Japan due to clonal expansion of ST235. PLoS ONE 2018, 13, e0207134. [Google Scholar] [CrossRef]
- Bebrone, C.; Bogaerts, P.; Delbrück, H.; Bennink, S.; Kupper, M.B.; Rezende de Castro, R.; Glupczynski, Y.; Hoffmann, K.M. GES-18, a new carbapenem-hydrolyzing GES-Type β-lactamase from Pseudomonas aeruginosa that contains Ile80 and Ser170 residues. Antimicrob. Agents Chemother. 2013, 57, 396–401. [Google Scholar] [CrossRef] [Green Version]
- Hagemann, J.B.; Pfennigwerth, N.; Gatermann, S.G.; Von Baum, H.; Essig, A. KPC-2 carbapenemase-producing Pseudomonas aeruginosa reaching Germany. J. Antimicrob. Chemother. 2018, 73, 1812–1814. [Google Scholar] [CrossRef]
- De Oliveira Santos, I.C.; Albano, R.M.; Asensi, M.D.; D’Alincourt Carvalho-Assef, A.P. Draft genome sequence of KPC-2-producing Pseudomonas aeruginosa recovered from a bloodstream infection sample in Brazil. J. Glob. Antimicrob. Resist. 2018, 15, 99–100. [Google Scholar] [CrossRef] [PubMed]
- Shi, L.; Liang, Q.; Feng, J.; Zhan, Z.; Zhao, Y.; Yang, W.; Yang, H.; Chen, Y.; Huang, M.; Tong, Y.; et al. Coexistence of two novel resistance plasmids, blaKPC-2-carrying p14057A and tetA(A)-carrying p14057B, in Pseudomonas aeruginosa. Virulence 2018, 9, 306–311. [Google Scholar] [CrossRef] [Green Version]
- Wolter, D.J.; Khalaf, N.; Robledo, I.E.; Vázquez, G.J.; Santé, M.I.; Aquino, E.E.; Goering, R.V.; Hanson, N.D. Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: Dissemination of KPC and IMP-18 beta-lactamases. Antimicrob. Agents Chemother. 2009, 53, 1660–1664. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jovcic, B.; Lepsanovic, Z.; Suljagic, V.; Rackov, G.; Begovic, J.; Topisirovic, L.; Kojic, M. Emergence of NDM-1 metallo-β-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia. Antimicrob. Agents Chemother. 2011, 55, 3929–3931. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Flateau, C.; Janvier, F.; Delacour, H.; Males, S.; Ficko, C.; Andriamanantena, D.; Jeannot, K.; Merens, A.; Rapp, C. Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012. Eurosurveillance 2012, 17, 20311. [Google Scholar] [PubMed]
- Ismail, S.J.; Mahmoud, S.S. First detection of New Delhi metallo-β-lactamases variants (NDM-1, NDM-2) among Pseudomonas aeruginosa isolated from Iraqi hospitals. Iran. J. Microbiol. 2018, 10, 98–103. [Google Scholar]
- Urbanowicz, P.; Izdebski, R.; Baraniak, A.; Żabicka, D.; Ziółkowski, G.; Hryniewicz, W.; Gniadkowski, M. Pseudomonas aeruginosa with NDM-1, DIM-1 and PME-1 β-lactamases, and RmtD3 16S rRNA methylase, encoded by new genomic islands. J. Antimicrob. Chemother. 2019, 74, 3117–3119. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chew, K.L.; Octavia, S.; Ng, O.T.; Marimuthu, K.; Venkatachalam, I.; Cheng, B.; Lin, R.T.P.; Teo, J.W.P. Challenge of drug resistance in Pseudomonas aeruginosa: Clonal spread of NDM-1-positive ST-308 within a tertiary hospital. J. Antimicrob. Chemother. 2019, 74, 2220–2224. [Google Scholar] [CrossRef]
- Liew, S.M.; Rajasekaram, G.; Puthucheary, S.D.; Chua, K.H. Detection of VIM-2-, IMP-1- and NDM-1-producing multidrug-resistant Pseudomonas aeruginosa in Malaysia. J. Glob. Antimicrob. Resist. 2018, 13, 271–273. [Google Scholar] [CrossRef]
- Pollini, S.; Maradei, S.; Pecile, P.; Olivo, G.; Luzzaro, F.; Docquier, J.-D.; Rossolini, G.M. FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob. Agents Chemother. 2013, 57, 410–416. [Google Scholar] [CrossRef] [Green Version]
- Boyd, D.A.; Lisboa, L.F.; Rennie, R.; Zhanel, G.G.; Dingle, T.C.; Mulvey, M.R. Identification of a novel metallo-β-lactamase, CAM-1, in clinical Pseudomonas aeruginosa isolates from Canada. J. Antimicrob. Chemother. 2019, 74, 1563–1567. [Google Scholar] [CrossRef] [PubMed]
- Sevillano, E.; Gallego, L.; García-Lobo, J.M. First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii. Pathol. Biol. 2009, 57, 493–495. [Google Scholar] [CrossRef]
- El Garch, F.; Bogaerts, P.; Bebrone, C.; Galleni, M.; Glupczynski, Y. OXA-198, an acquired carbapenem-hydrolyzing class D beta-lactamase from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2011, 55, 4828–4833. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Esenkaya Taşbent, F.; Özdemir, M. The presence of OXA type carbapenemases in Pseudomonas strains: First report from Turkey. Mikrobiyol. Bul. 2015, 49, 26–34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rouhi, S.; Ramazanzadeh, R. Prevalence of blaOxacillinase-23 and blaOxacillinase-24/40-type Carbapenemases in Pseudomonas aeruginosa Species Isolated from Patients with Nosocomial and Non-nosocomial Infections in the West of Iran. Iran. J. Pathol. 2018, 13, 348–356. [Google Scholar]
- Doi, Y.; Murray, G.L.; Peleg, A.Y. Acinetobacter baumannii: Evolution of antimicrobial resistance-treatment options. Semin. Respir. Crit. Care Med. 2015, 36, 85–98. [Google Scholar]
- Simo Tchuinte, P.L.; Rabenandrasana, M.A.N.; Kowalewicz, C.; Andrianoelina, V.H.; Rakotondrasoa, A.; Andrianirina, Z.Z.; Enouf, V.; Ratsima, E.H.; Randrianirina, F.; Collard, J.-M. Phenotypic and molecular characterisations of carbapenem-resistant Acinetobacter baumannii strains isolated in Madagascar. Antimicrob. Resist. Infect. Control 2019, 8, 31. [Google Scholar] [CrossRef]
- Nowak, P.; Paluchowska, P. Acinetobacter baumannii: Biology and drug resistance—Role of carbapenemases. Folia Histochem. Cytobiol. 2016, 54, 61–74. [Google Scholar] [CrossRef] [Green Version]
- Karthikeyan, K.; Thirunarayan, M.A.; Krishnan, P. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J. Antimicrob. Chemother. 2010, 65, 2253–2254. [Google Scholar] [CrossRef]
- Chen, Y.; Zhou, Z.; Jiang, Y.; Yu, Y. Emergence of NDM-1-producing Acinetobacter baumannii in China. J. Antimicrob. Chemother. 2011, 66, 1255–1259. [Google Scholar] [CrossRef]
- Decousser, J.W.; Jansen, C.; Nordmann, P.; Emirian, A.; Bonnin, R.A.; Anais, L.; Merle, J.C.; Poirel, L. Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013. Eurosurveillance 2013, 18, 20547. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Voulgari, E.; Politi, L.; Pitiriga, V.; Dendrinos, J.; Poulou, A.; Georgiadis, G.; Tsakris, A. First report of an NDM-1 metallo-β-lactamase-producing Acinetobacter baumannii clinical isolate in Greece. Int. J. Antimicrob. Agents 2016, 48, 761–762. [Google Scholar] [CrossRef] [PubMed]
- Hammerum, A.M.; Larsen, A.R.; Hansen, F.; Justesen, U.S.; Friis-Møller, A.; Lemming, L.E.; Fuursted, K.; Littauer, P.; Schønning, K.; Gahrn-Hansen, B.; et al. Patients transferred from Libya to Denmark carried OXA-48-producing Klebsiella pneumoniae, NDM-1-producing Acinetobacter baumannii and meticillin-resistant Staphylococcus aureus. Int. J. Antimicrob. Agents 2012, 40, 191–192. [Google Scholar] [CrossRef] [PubMed]
- Bogaerts, P.; Rezende de Castro, R.; Roisin, S.; Deplano, A.; Huang, T.-D.; Hallin, M.; Denis, O.; Glupczynski, Y. Emergence of NDM-1-producing Acinetobacter baumannii in Belgium. J. Antimicrob. Chemother. 2012, 67, 1552–1553. [Google Scholar] [CrossRef] [Green Version]
- Krizova, L.; Bonnin, R.A.; Nordmann, P.; Nemec, A.; Poirel, L. Characterization of a multidrug-resistant Acinetobacter baumannii strain carrying the blaNDM-1 and blaOXA-23 carbapenemase genes from the Czech Republic. J. Antimicrob. Chemother. 2012, 67, 1550–1552. [Google Scholar] [CrossRef] [Green Version]
- Bonnin, R.A.; Poirel, L.; Naas, T.; Pirs, M.; Seme, K.; Schrenzel, J.; Nordmann, P. Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe. Clin. Microbiol. Infect. 2012, 18, E362–E365. [Google Scholar] [CrossRef] [Green Version]
- Ghazawi, A.; Sonnevend, A.; Bonnin, R.A.; Poirel, L.; Nordmann, P.; Hashmey, R.; Rizvi, T.A.; B Hamadeh, M.; Pál, T. NDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates. Clin. Microbiol. Infect. 2012, 18, E34–E36. [Google Scholar] [CrossRef] [Green Version]
- Park, Y.K.; Jung, S.-I.; Park, K.-H.; Kim, S.H.; Ko, K.S. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea. Int. J. Antimicrob. Agents 2012, 39, 81–85. [Google Scholar] [CrossRef]
- Mugnier, P.D.; Poirel, L.; Nordmann, P. Functional analysis of insertion sequence ISAba1, responsible for genomic plasticity of Acinetobacter baumannii. J. Bacteriol. 2009, 191, 2414–2418. [Google Scholar] [CrossRef] [Green Version]
- Zhao, Y.; Hu, K.; Zhang, J.; Guo, Y.; Fan, X.; Wang, Y.; Mensah, S.D.; Zhang, X. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China. BMC Infect. Dis. 2019, 19, 452. [Google Scholar]
- Caldart, R.V.; Fonseca, E.L.; Freitas, F.; Rocha, L.; Vicente, A.C. Acinetobacter baumannii infections in Amazon Region driven by extensively drug resistant international clones, 2016–2018. Mem. Inst. Oswaldo Cruz 2019, 114, e190232. [Google Scholar] [CrossRef] [PubMed]
- Ewers, C.; Klotz, P.; Leidner, U.; Stamm, I.; Prenger-Berninghoff, E.; Göttig, S.; Semmler, T.; Scheufen, S. OXA-23 and ISAba1-OXA-66 class D β-lactamases in Acinetobacter baumannii isolates from companion animals. Int. J. Antimicrob. Agents 2017, 49, 37–44. [Google Scholar] [CrossRef] [PubMed]
- Al-Agamy, M.H.; Jeannot, K.; El-Mahdy, T.S.; Shibl, A.M.; Kattan, W.; Plésiat, P.; Courvalin, P. First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate. Microb. Drug Resist. Larchmt. N 2017, 23, 556–562. [Google Scholar] [CrossRef] [PubMed]
- Bonnin, R.A.; Nordmann, P.; Potron, A.; Lecuyer, H.; Zahar, J.-R.; Poirel, L. Carbapenem-hydrolyzing GES-type extended-spectrum beta-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 2011, 55, 349–354. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bonnin, R.A.; Rotimi, V.O.; Al Hubail, M.; Gasiorowski, E.; Al Sweih, N.; Nordmann, P.; Poirel, L. Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait. Antimicrob. Agents Chemother. 2013, 57, 183–188. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Robledo, I.E.; Aquino, E.E.; Santé, M.I.; Santana, J.L.; Otero, D.M.; León, C.F.; Vázquez, G.J. Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob. Agents Chemother. 2010, 54, 1354–1357. [Google Scholar] [CrossRef] [Green Version]
- Martínez, T.; Vázquez, G.J.; Aquino, E.E.; Martínez, I.; Robledo, I.E. ISEcp1-mediated transposition of blaKPC into the chromosome of a clinical isolate of Acinetobacter baumannii from Puerto Rico. J. Med. Microbiol. 2014, 63, 1644–1648. [Google Scholar] [CrossRef]
- Périchon, B.; Goussard, S.; Walewski, V.; Krizova, L.; Cerqueira, G.; Murphy, C.; Feldgarden, M.; Wortman, J.; Clermont, D.; Nemec, A.; et al. Identification of 50 class D β-lactamases and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp. Antimicrob. Agents Chemother. 2014, 58, 936–949. [Google Scholar] [CrossRef] [Green Version]
- Papp-Wallace, K.M.; Becka, S.A.; Zeiser, E.T.; Ohuchi, N.; Mojica, M.F.; Gatta, J.A.; Falleni, M.; Tosi, D.; Borghi, E.; Winkler, M.L.; et al. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients. ACS Infect. Dis. 2017, 3, 502–511. [Google Scholar] [CrossRef] [Green Version]
- Chi, X.; Zhang, J.; Xu, H.; Yu, X.; Shen, P.; Ji, J.; Ying, C.; Zheng, B.; Xiao, Y. Emergence of KPC-2-producing Raoultella ornithinolytica isolated from hospital wastewater treatment plant. Antimicrob. Agents Chemother. 2019. [Google Scholar] [CrossRef]
- Seng, P.; Boushab, B.M.; Romain, F.; Gouriet, F.; Bruder, N.; Martin, C.; Paganelli, F.; Bernit, E.; Le Treut, Y.P.; Thomas, P.; et al. Emerging role of Raoultella ornithinolytica in human infections: A series of cases and review of the literature. Int. J. Infect. Dis. 2016, 45, 65–71. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kieffer, N.; Guzmán-Puche, J.; Poirel, L.; Kang, H.J.; Jeon, C.O.; Nordmann, P. ZHO-1, an intrinsic MBL from the environmental Gram-negative species Zhongshania aliphaticivorans. J. Antimicrob. Chemother. 2019, 74, 1568–1571. [Google Scholar] [CrossRef] [PubMed]
- Kieffer, N.; Poirel, L.; Fournier, C.; Haltli, B.; Kerr, R.; Nordmann, P. Characterization of PAN-1, a Carbapenem-Hydrolyzing Class B β-Lactamase from the Environmental Gram-Negative Pseudobacteriovorax antillogorgiicola. Front. Microbiol. 2019, 10, 1673. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Ambler Carbapenemase Group | Enzyme Family | Representative Enzymes with Carbapenemase Activity | Country of Initial Detection | Species of Initial Detection | Location | Reference |
---|---|---|---|---|---|---|
Group A | NmcA | NmcA | France | Enterobacter cloacae | C | [11,12] |
SME | SME-1 | UK | Serratia marcescens | C | [42] | |
SME-4 | Argentina | S. marcescens | C | [46] | ||
IMI | IMI-1 | USA | E. cloacae | C | [47] | |
IMI-2 | USA | Enterobacter asburiae | P | [45] | ||
IMI-3 | Hong Kong | E. cloacae | P | [45] | ||
IMI-5 | Canada | E. cloacae | P | [48] | ||
IMI-6 | Canada | E. cloacae | P | [48] | ||
KPC | KPC-1 | USA | Klebsiella pneumoniae | P | [21] | |
KPC-2 | USA | K. pneumoniae | P | [49] | ||
KPC-3 | USA | K. pneumoniae | P | [49,50] | ||
Specific varieties of GES | GES-2 | South Africa | Pseudomonas aeruginosa | P | [65] | |
GES-5 | Spain | P. aeruginosa | C | [66] | ||
GES-11 | France | Acinetobacter baumannii | P | [69] | ||
GES-20 | Mexico | P. aeruginosa | C | [70] | ||
Group B | IMP | IMP-1 | Japan | P. aeruginosa | P | [13] |
IMP-2 | Italy | A. baumannii | P | [81] | ||
IMP-4 | USA | K. pneumoniae | P | [82] | ||
IMP-7 | Australia | P. aeruginosa | P | [84] | ||
VIM | VIM-1-like | Italy | P. aeruginosa | P | [16] | |
VIM-2-like | France | P. aeruginosa | P | [87] | ||
VIM-7-like | USA | P. aeruginosa | P | [89] | ||
NDM | NDM-1 | India | K. pneumoniae | P | [31] | |
NDM-2 | Egypt | A. baumannii | C | [100] | ||
NDM-3 | Japan | Escherichia coli | P | [101] | ||
NDM-4 | India | E. coli | P | [102] | ||
NDM-5 | UK | E. coli | P | [103] | ||
Emerging group C | ACT | ACT-28 | France | E. cloacae | C | [177] |
CMY | CMY-10 | Korea | E. cloacae | P | [178] | |
ADC | ADC-68 | Korea | A. baumannii | C | [179] | |
Group D | OXA | OXA-23 | Scotland | A. baumannii | P | [29] |
OXA-24/40 | Spain | A. baumannii | C, P | [137,140,141] | ||
OXA-58 | France | A. baumannii | P | [145] | ||
OXA-143 | Brazil | A. baumannii | P | [156] | ||
OXA-235 | USA and Mexico | A. baumannii | C, P | [161] | ||
OXA-48 | Turkey | K. pneumoniae | C, P | [25,165,166,167] |
Environmental or Animal Source | Bacterial Species | Detected Carbapenemase | Reference | |
---|---|---|---|---|
Animals | Poultry farm | Escherichia coli | NDM-5 | [98] |
Cats | Salmonella entericaserovarTyphimurium | IMP-4 | [85] | |
Wild mammals and birds | MultipleEnterobacteriaceaespecies | OXA-48 | [172] | |
Companion animals | Acinetobacter baumannii | OXA-48 | [173] | |
OXA-23 | [262] | |||
Cattle | A. baumannii | OXA-24 | [143] | |
Domestic parrot | A. baumannii | OXA-72 | [144] | |
Water | Wastewater | E. coli | KPC-2 | [63] |
Citrobacter freundii | OXA-204 | [171] | ||
Hospital wastewater | E. coli | KPC-2 | [64] | |
Raoltella ornitholitica | KPC-2 | [270] | ||
Acinetobacter towneri | OXA-58 | [154] | ||
Coastal water | A. towneri | OXA-58 | [155] | |
Municipal water | Acinetobacter lwoffii | OXA-235 and OXA-278 | [163] | |
River water | Klebsiella pneumoniae | KPC-2 | [216] | |
Estuarine water | Multiple Gram-negative environmental species | OXA-58 | [155] | |
Lake water | Pseudomonas otitidis | POM-1 | [97] | |
Environmental samples | Marine sediments | Zhongshania aliphaticivorans | ZHO-1 | [272] |
Soft coral | Pseudobacteriovorax antillogorgiicola | PAN-1 | [273] |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Hammoudi Halat, D.; Ayoub Moubareck, C. The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria. Antibiotics 2020, 9, 186. https://doi.org/10.3390/antibiotics9040186
Hammoudi Halat D, Ayoub Moubareck C. The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria. Antibiotics. 2020; 9(4):186. https://doi.org/10.3390/antibiotics9040186
Chicago/Turabian StyleHammoudi Halat, Dalal, and Carole Ayoub Moubareck. 2020. "The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria" Antibiotics 9, no. 4: 186. https://doi.org/10.3390/antibiotics9040186
APA StyleHammoudi Halat, D., & Ayoub Moubareck, C. (2020). The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria. Antibiotics, 9(4), 186. https://doi.org/10.3390/antibiotics9040186